An Open-label, Multicenter, Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) in Combination with Propranolol and G-CSF for the Mobilization of Hematopoietic Progenitor Cells in Multiple Myeloma Patients.

Yosra M Aljawai, Gunjan Shah, Ah-Reum Jeong, Muthalagu Ramanathan, Hyung C Suh, Michele Donato, John Hiemenz, Jonathan Licht, William Clark, Luke Paul Akard, Ann Woolfrey, Devki D Sukhtankar, Pina M Cardarelli, Niña G Caculitan, Jack Khouri

DOI: 10.1016/j.jtct.2026.10.047

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.